Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

VRSK vs CB vs ALL vs MMC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
VRSK
Verisk Analytics, Inc.

Consulting Services

IndustrialsNASDAQ • US
Market Cap$22.89B
5Y Perf.+1.2%
CB
Chubb Limited

Insurance - Property & Casualty

Financial ServicesNYSE • CH
Market Cap$125.37B
5Y Perf.+163.5%
ALL
The Allstate Corporation

Insurance - Property & Casualty

Financial ServicesNYSE • US
Market Cap$55.00B
5Y Perf.+118.5%
MMC
Marsh & McLennan Companies, Inc.

Insurance - Brokers

Financial ServicesNYSE • US
Market Cap$85.27B
5Y Perf.+77.7%

VRSK vs CB vs ALL vs MMC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
VRSK logoVRSK
CB logoCB
ALL logoALL
MMC logoMMC
IndustryConsulting ServicesInsurance - Property & CasualtyInsurance - Property & CasualtyInsurance - Brokers
Market Cap$22.89B$125.37B$55.00B$85.27B
Revenue (TTM)$3.10B$59.77B$67.14B$26.45B
Net Income (TTM)$910M$10.31B$12.14B$4.13B
Gross Margin67.4%29.4%39.8%42.3%
Operating Margin44.9%21.8%23.3%23.2%
Forward P/E22.9x11.9x7.9x16.9x
Total Debt$5.04B$22.19B$7.49B$21.86B
Cash & Equiv.$2.18B$2.47B$678M$2.40B

VRSK vs CB vs ALL vs MMCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

VRSK
CB
ALL
MMC
StockMay 20May 26Return
Verisk Analytics, I… (VRSK)100101.2+1.2%
Chubb Limited (CB)100263.5+163.5%
The Allstate Corpor… (ALL)100218.5+118.5%
Marsh & McLennan Co… (MMC)100177.7+77.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: VRSK vs CB vs ALL vs MMC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: VRSK and CB are tied at the top with 2 categories each — the right choice depends on your priorities. Chubb Limited is the stronger pick specifically for valuation and capital efficiency and recent price momentum and sentiment. ALL and MMC also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
VRSK
Verisk Analytics, Inc.
The Quality Compounder

VRSK has the current edge in this matchup, primarily because of its strength in quality and efficiency.

  • 29.3% margin vs MMC's 15.6%
  • 16.7% ROA vs CB's 4.0%, ROIC 33.0% vs 10.8%
Best for: quality and efficiency
CB
Chubb Limited
The Insurance Pick

CB is the #2 pick in this set and the best alternative if valuation efficiency is your priority.

  • PEG 0.44 vs VRSK's 2.68
  • Lower P/E (11.9x vs 16.9x), PEG 0.44 vs 0.88
  • +12.0% vs VRSK's -43.0%
Best for: valuation efficiency
ALL
The Allstate Corporation
The Insurance Pick

ALL is the clearest fit if your priority is income & stability and long-term compounding.

  • Dividend streak 12 yrs, beta 0.12, yield 1.8%
  • 258.7% 10Y total return vs CB's 187.6%
  • Lower volatility, beta 0.12, Low D/E 24.5%, current ratio 0.37x
  • Beta 0.12, yield 1.8%, current ratio 0.37x
Best for: income & stability and long-term compounding
MMC
Marsh & McLennan Companies, Inc.
The Insurance Pick

MMC is the clearest fit if your priority is growth exposure.

  • Rev growth 7.6%, EPS growth 8.6%, 3Y rev CAGR 7.3%
  • 7.6% revenue growth vs ALL's 4.6%
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthMMC logoMMC7.6% revenue growth vs ALL's 4.6%
ValueCB logoCBLower P/E (11.9x vs 16.9x), PEG 0.44 vs 0.88
Quality / MarginsVRSK logoVRSK29.3% margin vs MMC's 15.6%
Stability / SafetyALL logoALLBeta 0.12 vs MMC's 0.14, lower leverage
DividendsALL logoALL1.8% yield, 12-year raise streak, vs MMC's 1.8%
Momentum (1Y)CB logoCB+12.0% vs VRSK's -43.0%
Efficiency (ROA)VRSK logoVRSK16.7% ROA vs CB's 4.0%, ROIC 33.0% vs 10.8%

VRSK vs CB vs ALL vs MMC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

VRSKVerisk Analytics, Inc.
FY 2025
Insurance
100.0%$2.2B
CBChubb Limited
FY 2025
Segment Life
100.0%$7.2B
ALLThe Allstate Corporation
FY 2025
Property Liability
93.4%$59.7B
Protection Services
5.6%$3.5B
Allstate Health And Benefits
1.1%$676M
MMCMarsh & McLennan Companies, Inc.
FY 2024
Risk and Insurance Services Segment
62.8%$15.4B
Consulting Segment
37.2%$9.1B

VRSK vs CB vs ALL vs MMC — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLVRSKLAGGINGMMC

Income & Cash Flow (Last 12 Months)

VRSK leads this category, winning 4 of 6 comparable metrics.

ALL is the larger business by revenue, generating $67.1B annually — 21.6x VRSK's $3.1B. VRSK is the more profitable business, keeping 29.3% of every revenue dollar as net income compared to MMC's 15.6%. On growth, MMC holds the edge at +11.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricVRSK logoVRSKVerisk Analytics,…CB logoCBChubb LimitedALL logoALLThe Allstate Corp…MMC logoMMCMarsh & McLennan …
RevenueTrailing 12 months$3.1B$59.8B$67.1B$26.5B
EBITDAEarnings before interest/tax$1.7B$13.3B$16.0B$7.0B
Net IncomeAfter-tax profit$910M$10.3B$12.1B$4.1B
Free Cash FlowCash after capex$1.1B$13.5B$11.5B$5.1B
Gross MarginGross profit ÷ Revenue+67.4%+29.4%+39.8%+42.3%
Operating MarginEBIT ÷ Revenue+44.9%+21.8%+23.3%+23.2%
Net MarginNet income ÷ Revenue+29.3%+17.2%+18.1%+15.6%
FCF MarginFCF ÷ Revenue+36.3%+22.6%+17.2%+19.3%
Rev. Growth (YoY)Latest quarter vs prior year+3.9%+7.9%+4.2%+11.5%
EPS Growth (YoY)Latest quarter vs prior year+4.8%+28.0%+3.4%0.0%
VRSK leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

ALL leads this category, winning 6 of 7 comparable metrics.

At 5.6x trailing earnings, ALL trades at a 79% valuation discount to VRSK's 26.9x P/E. Adjusting for growth (PEG ratio), ALL offers better value at 0.33x vs VRSK's 3.16x — a lower PEG means you pay less per unit of expected earnings growth.

MetricVRSK logoVRSKVerisk Analytics,…CB logoCBChubb LimitedALL logoALLThe Allstate Corp…MMC logoMMCMarsh & McLennan …
Market CapShares × price$22.9B$125.4B$55.0B$85.3B
Enterprise ValueMkt cap + debt − cash$25.7B$145.1B$61.8B$104.7B
Trailing P/EPrice ÷ TTM EPS26.92x12.49x5.59x21.28x
Forward P/EPrice ÷ next-FY EPS est.22.85x11.87x7.87x16.89x
PEG RatioP/E ÷ EPS growth rate3.16x0.46x0.33x1.11x
EV / EBITDAEnterprise value multiple15.34x10.87x4.53x15.96x
Price / SalesMarket cap ÷ Revenue7.45x2.10x0.83x3.49x
Price / BookPrice ÷ Book value/share78.44x1.60x1.85x6.38x
Price / FCFMarket cap ÷ FCF19.20x8.62x5.57x21.39x
ALL leads this category, winning 6 of 7 comparable metrics.

Profitability & Efficiency

VRSK leads this category, winning 6 of 9 comparable metrics.

VRSK delivers a 4.4% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $14 for CB. ALL carries lower financial leverage with a 0.24x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRSK's 16.26x. On the Piotroski fundamental quality scale (0–9), CB scores 7/9 vs VRSK's 5/9, reflecting strong financial health.

MetricVRSK logoVRSKVerisk Analytics,…CB logoCBChubb LimitedALL logoALLThe Allstate Corp…MMC logoMMCMarsh & McLennan …
ROE (TTM)Return on equity+4.4%+13.6%+42.7%+26.9%
ROA (TTM)Return on assets+16.7%+4.0%+10.1%+7.0%
ROICReturn on invested capital+33.0%+10.8%+29.8%+15.2%
ROCEReturn on capital employed+39.6%+5.3%+29.4%+17.8%
Piotroski ScoreFundamental quality 0–95776
Debt / EquityFinancial leverage16.26x0.28x0.24x1.62x
Net DebtTotal debt minus cash$2.9B$19.7B$6.8B$19.5B
Cash & Equiv.Liquid assets$2.2B$2.5B$678M$2.4B
Total DebtShort + long-term debt$5.0B$22.2B$7.5B$21.9B
Interest CoverageEBIT ÷ Interest expense7.87x18.07x40.22x6.66x
VRSK leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

ALL leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in CB five years ago would be worth $19,205 today (with dividends reinvested), compared to $10,182 for VRSK. Over the past 12 months, CB leads with a +12.0% total return vs VRSK's -43.0%. The 3-year compound annual growth rate (CAGR) favors ALL at 24.7% vs VRSK's -5.1% — a key indicator of consistent wealth creation.

MetricVRSK logoVRSKVerisk Analytics,…CB logoCBChubb LimitedALL logoALLThe Allstate Corp…MMC logoMMCMarsh & McLennan …
YTD ReturnYear-to-date-20.7%+3.9%+5.4%-3.6%
1-Year ReturnPast 12 months-43.0%+12.0%+6.7%-22.0%
3-Year ReturnCumulative with dividends-14.5%+66.4%+93.9%+2.0%
5-Year ReturnCumulative with dividends+1.8%+92.1%+75.3%+36.5%
10-Year ReturnCumulative with dividends+137.1%+187.6%+258.7%+209.8%
CAGR (3Y)Annualised 3-year return-5.1%+18.5%+24.7%+0.7%
ALL leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — VRSK and ALL each lead in 1 of 2 comparable metrics.

VRSK is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than MMC's 0.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALL currently trades 96.2% from its 52-week high vs VRSK's 54.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricVRSK logoVRSKVerisk Analytics,…CB logoCBChubb LimitedALL logoALLThe Allstate Corp…MMC logoMMCMarsh & McLennan …
Beta (5Y)Sensitivity to S&P 500-0.04x-0.01x0.12x0.14x
52-Week HighHighest price in past year$322.92$345.67$222.22$235.78
52-Week LowLowest price in past year$161.70$264.10$188.08$170.37
% of 52W HighCurrent price vs 52-week peak+54.1%+92.9%+96.2%+73.8%
RSI (14)Momentum oscillator 0–10039.542.956.437.2
Avg Volume (50D)Average daily shares traded1.9M1.6M1.3M2.7M
Evenly matched — VRSK and ALL each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — ALL and MMC each lead in 1 of 2 comparable metrics.

Analyst consensus: VRSK as "Hold", CB as "Buy", ALL as "Buy", MMC as "Hold". Consensus price targets imply 32.4% upside for VRSK (target: $231) vs 7.2% for CB (target: $344). For income investors, ALL offers the higher dividend yield at 1.83% vs VRSK's 1.03%.

MetricVRSK logoVRSKVerisk Analytics,…CB logoCBChubb LimitedALL logoALLThe Allstate Corp…MMC logoMMCMarsh & McLennan …
Analyst RatingConsensus buy/hold/sellHoldBuyBuyHold
Price TargetConsensus 12-month target$231.25$344.33$244.38$206.75
# AnalystsCovering analysts25434426
Dividend YieldAnnual dividend ÷ price+1.0%+1.2%+1.8%+1.8%
Dividend StreakConsecutive years of raises791219
Dividend / ShareAnnual DPS$1.81$3.80$3.91$3.05
Buyback YieldShare repurchases ÷ mkt cap+2.7%+2.9%+2.2%+1.1%
Evenly matched — ALL and MMC each lead in 1 of 2 comparable metrics.
Key Takeaway

VRSK leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ALL leads in 2 (Valuation Metrics, Total Returns). 2 tied.

Best OverallVerisk Analytics, Inc. (VRSK)Leads 2 of 6 categories
Loading custom metrics...

VRSK vs CB vs ALL vs MMC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is VRSK or CB or ALL or MMC a better buy right now?

For growth investors, Marsh & McLennan Companies, Inc.

(MMC) is the stronger pick with 7. 6% revenue growth year-over-year, versus 4. 6% for The Allstate Corporation (ALL). The Allstate Corporation (ALL) offers the better valuation at 5. 6x trailing P/E (7. 9x forward), making it the more compelling value choice. Analysts rate Chubb Limited (CB) a "Buy" — based on 43 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — VRSK or CB or ALL or MMC?

On trailing P/E, The Allstate Corporation (ALL) is the cheapest at 5.

6x versus Verisk Analytics, Inc. at 26. 9x. On forward P/E, The Allstate Corporation is actually cheaper at 7. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Chubb Limited wins at 0. 44x versus Verisk Analytics, Inc. 's 2. 68x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — VRSK or CB or ALL or MMC?

Over the past 5 years, Chubb Limited (CB) delivered a total return of +92.

1%, compared to +1. 8% for Verisk Analytics, Inc. (VRSK). Over 10 years, the gap is even starker: ALL returned +258. 7% versus VRSK's +137. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — VRSK or CB or ALL or MMC?

By beta (market sensitivity over 5 years), Verisk Analytics, Inc.

(VRSK) is the lower-risk stock at -0. 04β versus Marsh & McLennan Companies, Inc. 's 0. 14β — meaning MMC is approximately -483% more volatile than VRSK relative to the S&P 500. On balance sheet safety, The Allstate Corporation (ALL) carries a lower debt/equity ratio of 24% versus 16% for Verisk Analytics, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — VRSK or CB or ALL or MMC?

By revenue growth (latest reported year), Marsh & McLennan Companies, Inc.

(MMC) is pulling ahead at 7. 6% versus 4. 6% for The Allstate Corporation (ALL). On earnings-per-share growth, the picture is similar: The Allstate Corporation grew EPS 124. 8% year-over-year, compared to -3. 3% for Verisk Analytics, Inc.. Over a 3-year CAGR, CB leads at 11. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — VRSK or CB or ALL or MMC?

Verisk Analytics, Inc.

(VRSK) is the more profitable company, earning 29. 6% net margin versus 15. 5% for The Allstate Corporation — meaning it keeps 29. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VRSK leads at 44. 6% versus 19. 8% for ALL. At the gross margin level — before operating expenses — VRSK leads at 67. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is VRSK or CB or ALL or MMC more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Chubb Limited (CB) is the more undervalued stock at a PEG of 0. 44x versus Verisk Analytics, Inc. 's 2. 68x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, The Allstate Corporation (ALL) trades at 7. 9x forward P/E versus 22. 9x for Verisk Analytics, Inc. — 15. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VRSK: 32. 4% to $231. 25.

08

Which pays a better dividend — VRSK or CB or ALL or MMC?

All stocks in this comparison pay dividends.

The Allstate Corporation (ALL) offers the highest yield at 1. 8%, versus 1. 0% for Verisk Analytics, Inc. (VRSK).

09

Is VRSK or CB or ALL or MMC better for a retirement portfolio?

For long-horizon retirement investors, Chubb Limited (CB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

01), 1. 2% yield, +187. 6% 10Y return). Both have compounded well over 10 years (CB: +187. 6%, MMC: +209. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between VRSK and CB and ALL and MMC?

These companies operate in different sectors (VRSK (Industrials) and CB (Financial Services) and ALL (Financial Services) and MMC (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: VRSK is a mid-cap quality compounder stock; CB is a mid-cap deep-value stock; ALL is a mid-cap deep-value stock; MMC is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

VRSK

Quality Mega-Cap Compounder

  • Sector: Industrials
  • Market Cap > $100B
  • Net Margin > 17%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

CB

Stable Dividend Mega-Cap

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 10%
Run This Screen
Stocks Like

ALL

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Net Margin > 10%
  • Dividend Yield > 0.7%
Run This Screen
Stocks Like

MMC

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform VRSK and CB and ALL and MMC on the metrics below

Revenue Growth>
%
(VRSK: 3.9% · CB: 7.9%)
Net Margin>
%
(VRSK: 29.3% · CB: 17.2%)
P/E Ratio<
x
(VRSK: 26.9x · CB: 12.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.